SCHEMBL875780

SCHEMBL875780

Cc1cccn2c(=O)c(CC(C)(C)CC(N)=O)c(Cl)nc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
MAPT P10636 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
RECQL P46063 1/20 0.49
HSD17B10 Q99714 5/20 0.41
CASP1 P29466 3/20 0.41
CASP7 P55210 1/20 0.41
TP53 P04637 3/20 0.41
ALDH1A1 P00352 3/20 0.41
GAA P10253 3/20 0.41
HPGD P15428 3/20 0.41
PABPC1 P11940 1/20 0.41
HTT P42858 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
RAB9A P51151 1/20 0.40
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
POLB P06746 1/20 0.38
THRB P10828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL875789 0.82 LMNA (0.42) KDM4EMAPTNPSR1HSD17B10CASP1
SCHEMBL875494 0.72 KDM4E (0.50) KDM4EMAPTNPSR1RECQLHSD17B10
SCHEMBL2217810 0.72 KDM4E (0.62) KDM4EMAPTNPSR1RECQLHSD17B10
SCHEMBL15887186 0.72 KDM4E (0.62) KDM4EMAPTNPSR1RECQLHSD17B10
SCHEMBL876284 0.71 KDM4E (0.65) KDM4EMAPTNPSR1RECQLHSD17B10
SCHEMBL875250 0.70 RORC (0.38) KDM4EMAPTTP53ALDH1A1HPGD
SCHEMBL876287 0.70 MAPT (0.35) MAPTTP53MEN1KMT2ALMNA
SCHEMBL2216295 0.69 MAPT (0.58) KDM4EMAPTNPSR1RECQLHSD17B10
SCHEMBL875212 0.68 GUCY1B2 (0.34) KDM4EMAPTHPGDMEN1KMT2A
SCHEMBL875508 0.67 PRSS1 (0.35) MAPTTP53KMT2ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2619202-A1 PYRIDMIDONES FOR TREATMENT OF POTASSIUM CHANNEL RELATED DISEASES Pfizer Inc (US) 2013-07-31 EP disclosed
WO-2012038850-A1 PYRIDMIDONES FOR TREATMENT OF POTASSIUM CHANNEL RELATED DISEASES PFIZER INC. (US) 2012-03-29 WO disclosed